![]() |
submitted by /u/provi6 [link] [comments] |
AstraZeneca signs $2 bln agreement with Quell to develop cell therapies
AstraZeneca signs $2 bln agreement with Quell to develop cell therapies The agreement includes developing, manufacturing and commercialising cell therapies that have the potential to be curative in type 1 diabetes and inflammatory bowel disease indications. https://ift.tt/jLN6SH4
Government gives nod to sale of 2 fixed-dose combination drugs
Government gives nod to sale of 2 fixed-dose combination drugs FDC– drugs made by combining two or more drugs in certain fixed dose combinations – were found to be rational by the expert committee. https://ift.tt/jLN6SH4
Subscribe to:
Comments (Atom)
Subscribe UsPopular Posts
|




